200020091

ACVR2A Monoclonal Antibody (C1), Invitrogen™

Mouse Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

ACVR2A

Concentration

1 mg/mL

Classification

Monoclonal

Form

Liquid

Regulatory Status

RUO

Formulation

PBS with 50% glycerol and 0.05% Proclin 300, pH 7.4

Gene Alias

activin A receptor type 2A, activin A receptor type IIA, activin A receptor, type IIA, activin receptor IIA, activin receptor type IIA, Activin receptor type-2A, Actrii, ActrIIa, ACTR-IIA, ACVR2, Acvr2a, rActR-II, TactrII, type II activin receptor

Gene Symbols

ACVR2A

Isotype

IgG2b κ

Purification Method

Protein A/G

Gene

ACVR2A

Clone

C1

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Conjugate

Unconjugated

Host Species

Mouse

Target Species

Human, Porcine

Gene Accession No.

P27037

Gene ID (Entrez)

397282, 92

Immunogen

Recombinant Human ACVR2A protein, Ala20-Pro135 (Accession #P27037)

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Related Products

Img

Fischer Scientific

200020200

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020345

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020430

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020225

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020225

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020347

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020192

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200020171

Mouse Monoclonal Antibody...

Description

  • Activin A receptor kinase (ACVR2A) is a type II member of the TGF-beta family of receptor Serine/Threonine kinases
  • ACVR2A is involved in the activin and myostatin signaling pathway
  • (ACVR2A Aliases: ACVR2, ACTRII)
  • These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity
  • Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors
  • Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors
  • Type II receptors are considered to be constitutively active kinases.